Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports

Author(s):  Haase Mark R, Luedtke Sherry, Robles Janie, Parker Thomas, Leff Rich, Giacoia George

Issue:  Jan/Feb 2009 - Compounding for Pediatrics
View All Articles in Issue

Page(s):  14-18

Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports Page 1
Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports Page 2
Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports Page 3
Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports Page 4
Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports Page 5

Download in electronic PDF format for $75

Abstract:  This report is the first to replicate the earlier findings of Standing et al and validates the inadequacy of reporting of dosage forms used in pediatric drug trials. Journal authors should provide and journal editors should require adequate dosage form information for published reports of pediatric drug trials. We also recommend that compounding pharmacists provide detailed compounding instructions to assure that extemporaneously compounded formulations can be reliably reproduced, and that quality-control data be provided to support formulation stability. Until the problem of insuffi cient information is addressed, replication of many pediatric drug trials is impossible, calling into question their reliability and validity.

Related Keywords: children, dosage forms, clinical drug trials, journals

Related Categories: PEDIATRICS, DOSAGE FORMS/DRUG CARRIERS, INFORMATION RESOURCES

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports
Haase Mark R
, Luedtke Sherry, Robles Janie, Parker Thomas, Leff Rich, Giacoia George
Jan/Feb 2009
Pg. 14-18

Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms
Akers Michael J
Jan/Feb 2017
Pg. 47-56

Formulation Development of Modafinil Sprinkle Dosage Form: Study on the Effect of Food on Dosage
Kumaravelrajan Rajagopal
, Karthik B, Venkatasan Suba
Nov/Dec 2022
Pg. 516-521

Basics: A Review: In Situ Gel Dosage Forms for Herbal Medicine Delivery
Rachmawati Putriana
Jan/Feb 2023
Pg. 24-29

Single-Patient Trials, Extemporaneously Compounded Products and Pharmaceutical Care
Fassett William E
Nov/Dec 2003
Pg. 441-447

Basics of Compounding: Unique and Special Characteristics of Sterile Dosage Forms
Akers Michael J
Nov/Dec 2014
Pg. 479-484

PreScription: A New Dosage Form
Allen Loyd V Jr
Sep/Oct 2022
Pg. 356

Does Your Drug Expertise Include Clinical Pharmaceutics?
Newton David W
May/Jun 2016
Pg. 202-206

Basics of Compounding: Foam Dosage Forms
Allen Loyd V Jr
Jul/Aug 2013
Pg. 312-322

Compliance to Treatment in Elderly Dysphagic Patients: Potential Benefits of Alternate Dosage Forms
Bramwell Bethany L
Nov/Dec 2009
Pg. 498-505

Stability of Oral Liquid Dosage Forms of Glycopyrrolate Prepared with the Use of Powder
Gupta Vishnu D
Sep/Oct 2003
Pg. 386-388

Lollipops: The Evolution of a Dosage Form
Mason Dave
, Fields Shannon
May/Jun 2002
Pg. 178-179

Quality Control Analytical Methods: Considerations in Compounding Peroral Solid Dosage Forms
Vu Nicole
Mar/Apr 2007
Pg. 145-148

Chemical Stability of Perphenazine in Two Commercially Available Vehicles for Oral Liquid Dosage Forms
Gupta Vishnu D
Jul/Aug 2008
Pg. 372-374

Pediatric Compounding: Coloring Outside the Lines
Preckshot John
Jan/Feb 2001
Pg. 6-8

Basics of Compounding: 3D Printing--Pharmacy Applications, Part 1
Allen Loyd V Jr
Mar/Apr 2017
Pg. 127-130

Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2
Giacoia George P
, Taylor-Zapata Perdita, Mattison Donald
May/Jun 2007
Pg. 220-225

Basics of Compounding: Clinical Pharmaceutics, Part 1
Allen Loyd V Jr
Sep/Oct 2016
Pg. 389-396

Filling the Gaps on the Institute for Safe Medication Practices (ISMP) Do Not Crush List for Immediate-release Products
Uttaro Elizabeth
, Zhao Fang, Schweighardt Anne
Sep/Oct 2021
Pg. 364-371

Unit Dose Packaging and Repackaging of Solid and Liquid Dosage Forms in an Institutional Setting
McElhiney Linda F
Jan/Feb 2010
Pg. 32-38

Return to Top